Chemical activators of Nim1 function by modulating intracellular signaling pathways that lead to the protein's activation. Forskolin is a well-known activator of adenylate cyclase, which catalyzes the conversion of ATP to cyclic AMP (cAMP). The increase in cAMP levels results in the activation of protein kinase A (PKA), a key kinase that can phosphorylate and thereby activate Nim1. Similarly, 8-Bromo-cAMP, a cAMP analog, can permeate cell membranes and directly activate PKA, which in turn phosphorylates and activates Nim1. Isoproterenol, a beta-adrenergic agonist, enhances cAMP production by stimulating adenylate cyclase via the beta-adrenergic receptor, leading to PKA activation and subsequent Nim1 phosphorylation and activation.
Rolipram and IBMX act as phosphodiesterase inhibitors, preventing the breakdown of cAMP and thereby sustaining an elevated level of this messenger molecule within the cell. This persistence of cAMP prolongs the activation state of PKA, which then consistently activates Nim1. Prostaglandin E1 (PGE1) and Epinephrine, through interaction with their respective receptors, also raise cAMP levels. PGE1 binds to its receptor leading to adenylate cyclase activation, whereas epinephrine interacts with beta-adrenergic receptors achieving the same effect. Both routes culminate in the PKA-mediated activation of Nim1. Glucagon, by binding to its specific receptor, and Terbutaline and Salbutamol, by activating beta2-adrenergic receptors, all enhance cAMP levels, enabling PKA activation and in turn, the activation of Nim1.
Dibutyryl-cAMP, another cell-permeable analog of cAMP, directly activates PKA, bypassing the receptor-mediated steps and leading to Nim1 activation. Lastly, Anagrelide inhibits phosphodiesterase III, resulting in increased cAMP and PKA activation. The common thread among these chemical activators is their ability to raise intracellular cAMP levels, either by promoting its production, mimicking its action, or inhibiting its degradation, which leads to the activation of PKA and the subsequent activation of Nim1 through phosphorylation. This cascade of events highlights the pivotal role of cAMP and PKA in the regulation and activation of Nim1, underscoring the importance of these signaling molecules in cellular processes.
VEJA TAMBÉM
| Nome do Produto | CAS # | Numero de Catalogo | Quantidade | Preco | Uso e aplicacao | NOTAS |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
A forskolina aumenta diretamente os níveis de AMPc, que são conhecidos por ativar a Nim1, promovendo a ativação da proteína quinase A (PKA), que pode fosforilar e assim ativar a Nim1. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $106.00 $166.00 $289.00 $550.00 $819.00 | 2 | |
O 8-Bromo-cAMP é um análogo do cAMP permeável às células que ativa a PKA, levando à fosforilação e ativação da Nim1. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
O rolipram inibe a fosfodiesterase-4, impedindo a degradação do AMPc, o que contribui para a ativação da PKA e a subsequente ativação da Nim1. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
O IBMX é um inibidor não seletivo da fosfodiesterase que impede a degradação do AMPc, aumentando a atividade da PKA e conduzindo assim potencialmente à ativação da Nim1. | ||||||
PGE1 (Prostaglandin E1) | 745-65-3 | sc-201223 sc-201223A | 1 mg 10 mg | $30.00 $142.00 | 16 | |
A prostaglandina E1 (PGE1) aumenta os níveis de cAMP, activando a PKA, que por sua vez pode fosforilar e ativar a Nim1. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $40.00 $102.00 $197.00 $1739.00 $16325.00 | ||
A epinefrina interage com os receptores beta-adrenérgicos, aumentando os níveis de AMPc e activando a PKA, que pode ativar a Nim1. | ||||||
Terbutaline Hemisulfate | 23031-32-5 | sc-204911 sc-204911A | 1 g 5 g | $90.00 $371.00 | 2 | |
A terbutalina, um agonista dos receptores beta2-adrenérgicos, aumenta os níveis de cAMP, activando a PKA, o que pode levar à ativação da Nim1. | ||||||
Salbutamol | 18559-94-9 | sc-253527 sc-253527A | 25 mg 50 mg | $92.00 $138.00 | ||
O salbutamol ativa os receptores beta2-adrenérgicos, levando ao aumento do AMPc e à ativação da PKA, que pode ativar a Nim1. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
O dibutiril-AMP é outro análogo do AMPc permeável às células que ativa a PKA, levando à potencial ativação da Nim1. | ||||||